A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol outlines the fabrication of lipid microbubbles and a compatible one-pot microbubble radiolabeling method with purification-free >95% labeling efficiency that conserves microbubble physicochemical properties. This method is effective across diverse lipid microbubble formulations and can be tailored to generate radioactive and/or fluorescent microbubbles.
Microbubbles are lipid-shelled, gas-filled particles that have evolved from vascular ultrasound contrast agents into revolutionary cancer therapy platforms. When combined with therapeutic focused ultrasound (FUS), they can safely and locally overcome physiological barriers (e.g., blood-brain barrier), deliver drugs to otherwise inaccessible cancers (e.g., glioblastoma and pancreatic cancer), and treat neurodegenerative diseases. The therapeutic arsenal of microbubble-FUS is advancing in new directions, including synergistic combination radiotherapy, multimodal imaging, and all-in-one drug loading and delivery from microbubble shells.
Labeling microbubbles with radiotracers is key to establishing these expanded theranostic capabilities. However, existing microbubble radiolabeling strategies rely on purification methodologies known to perturb microbubble physicochemical properties, use short-lived radioisotopes, and do not always yield stable chelation. Collectively, this creates ambiguity surrounding the accuracy of microbubble radioimaging and the efficiency of tumor radioisotope delivery.
This protocol describes a new one-pot, purification-free microbubble labeling methodology that preserves microbubble physicochemical properties while achieving >95% radioisotope chelation efficiency. It is versatile and can be applied successfully across custom and commercial microbubble formulations with differing acyl lipid chain length, charge, and chelator/probe (porphyrin, DTPA, DiI) composition. It can be adaptively applied during ground-up microbubble fabrication and to pre-made microbubble formulations with modular customizability of fluorescence and multimodal fluorescence/radioactive properties. Accordingly, this flexible method enables the production of tailored, traceable (radio, fluorescent, or radio/fluorescent active) multimodal microbubbles that are useful for advancing mechanistic, imaging, and therapeutic microbubble-FUS applications.
Microbubbles are micron-sized supramolecular theranostic agents with a gas core stabilized by a protein, polymer, or, in most cases, a lipid shell (Figure 1A). When injected into the bloodstream, microbubbles maintain gas/liquid interfaces that are detectable by ultrasound for minutes-long timeframes prior to the dissolution of their gas cores1,2. Consequently, the first clinical use of microbubbles was as real-time ultrasound imaging contrast agents3. The invention of therapeutic focused ultrasound (FUS) expanded microbubble clinical utilities. When stimul....
1. Preparations of reagents
The key quantifiable results when fabricating radiolabeled microbubbles are radiochemical purity and radiolabeling efficiency. This protocol uses iTLC and a validated centrifugal procedure, respectively, to characterize each. Figure 2A shows that average radiochemical purities and efficiencies of ≥95% were achieved across commercial microbubble mimicking formulations in which the host lipid was substituted for pyro-lipid at compositions of 1 mol%, 10 mol%, or 30 mol% of the total lipid.......
The current lipid microbubble radiolabeling protocol achieves >95% radiochemical purity, >95% chelation efficiency, and retention of microbubble physicochemical properties without necessitating any post-labeling purification. These accomplishments represent advancements previously unattained for existing labeling protocols. Lack of purification steps allows quicker use of radioisotopes (in this case, copper-64), and thus, reduction of inefficient activity loss from radioactive decay. The resulting retention of mi.......
We thank Deborah Scollard and Teesha Komal (University Health Network Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program, Toronto, Ontario) for their technical services and guidance. We also thank Mark Zheng and Dr. Alex Dhaliwal for their technical assistance during confocal microscopy and the Advanced Optical Microscopy Facility (Toronto, Ontario) for providing associated equipment. We acknowledge our funding sources: the Canadian Institutes of Health Research, the Terry Fox Research Institute, the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, the Princess Margaret Cancer Foundation....
Name | Company | Catalog Number | Comments |
64CuCl2 | Washington University School of Medicine, Mallinckrodt Institute of Radiology | N/A | Order in small volume (<10 µL) dissolved in 0.1 N HCl |
Acetic acid | Any company | ≥ 95% purity | |
Aluminum foil | Any company | ||
Ammonium acetate | Any company | Purity: ≥ 98% | |
Balance - analytical | Any company | Able to measure down to 0.1 mg | |
Bath sonicator | Any company | Can be heated to 69 oC | |
CC aperture - 30 micron | Beckman Coulter | A36391 | Particle diameter range: 0.6-18 um |
CC electrolyte | Beckman Coulter | 8546719 | Isoton II diluent |
CC Software | Beckman Coulter | Multisizer 4e | |
Centrifuge filter units (0.5 mL 30,000 MWCO) with compatible microcentrifuge tubes | MilliporeSigma | UFC503096 | Amicon Ultra - 0.5 mL |
Centrifuge tubes - 15 mL with caps | Any company | ||
Chloroform | Any company | Purity: ≥ 99.8% | |
Coulter counter | Beckman Coulter | B43905 | Multisizer 4e Coulter Counter |
Cover slips | VWR | 48393081 | VWR micro cover glass |
CuCl2 | Any company | Ensure not oxidized | |
CuCl2 | |||
Cuvette- quarts, 1 cm path length | Any company | ||
Cuvettes - 10 mL plastic for CC measurements | Beckman Coulter | A35471 | Coulter Counter Accuvette ST |
ddH2O | Any company | Can be obtained through an ultrapure water purification system | |
DiI (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine Perchlorate) | Any company | Powder form | |
Dose calibrator | Any company | Able to read copper-64 | |
DPPA (1,2-dipalmitoyl-sn-glycero-3-phosphate (sodium salt)) | Avanti Polar Lipids | 830855P | Powder form |
DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) | Avanti Polar Lipids | 850355P | Powder form |
DPPE-MPEG (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt)) | Avanti Polar Lipids | 880200P | Powder form |
DTPA-lipid (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (ammonium salt)) | Avanti Polar Lipids | 790106P | Powder form |
EDTA (Ethylenediaminetetraacetic acid) | Any company | ||
Gamma counter | Any company | Able to read copper-64 | |
Gamma counting tube push caps | Globe Scientific | 22-171-665 | Flanged plug caps for 12 mm tubes |
Gamma counting tubes | Sarstedt | 55.1579 | 5 mL, 75 x 12 mm, PS |
Glass beaker - 250 mL | Any company | Able to withstand temperatures up to 100 oC | |
Glass drying oven | Any company | Can be heated to 80 oC | |
Glass microliter syringes - 25, 50, 100, 1000 µL | Any company | Compatible with organic solvents | |
Glass scintillation vials - 20 mL | VWR | 66022-081 | VWR® Scintillation Vials, Borosilicate Glass, with Screw Caps, With pulp foil liner |
Glass vials - 0.5 dram | VWR | 66011-020 | VWR Vial 1/2 dram, with black phenolic screw cap and polyvinyl-faced pulp liner |
Glycerol | Sigma Aldrich | G7757-1L | Purity: ≥ 99.0% |
Graduated pipette/gun | Any company | ||
Hot/stir plate | Equipped with temperature prob for automatic tempearture control | ||
Hydrochloric acid - 0.1 N | Any company | ||
iTLC plates | Agilent | A120B12 | iTLC-SA chromatography paper |
Laboratory tissues | Any company | ||
Media vaccuum filtration unit | Any company | 0.22 micron pore size, PES membrane, 500 mL funnel capacity | |
Methanol | Any company | Purity: ≥ 99.8%, HPLC grade, meets ACS specifications | |
Microcentrifuge tubes non sterile - 1.5 mL | Any company | ||
Microcentrifuge tubes sterile - 1.5 mL | Any company | ||
Micropipetes - p1000, p200, p20, p10 | Any company | Ensure are calibrated | |
Microscope slides | Fisher Scientific | 12-550-15 | Superfrost Plus Microscope Slides Precleaned |
Needles - 18 G | Sterile | ||
Parafilm | Any company | ||
PBS | Sigma Aldrich | D8537-500ML | DPBS, modified, without calcium chloride and magnesium chloride, liquid, sterile-filtered, suitable for cell culture |
PFP | FluoroMed | APF-N40HP | Purity: ≥ 99.8% |
PFP line | Any company | 1/4 inch diameter plastic hose cut about 50 cm in length | |
PFP regulator | Swagelok | SS-1RF4 and SS-4HC-1-4 | |
pH meter | Any company | ||
pH standards 4 and 7 | Any company | ||
Pipette tips for p1000, p200, p10 - non sterile | Any company | ||
Pipette tips for p1000, p200, p10 - sterile | Any company | ||
Plastic syringe - 1 mL | Any company | Sterile | |
Propylene glycol | BioShop | PRO888.500 | Purity: ≥ 99.5% |
Pyro-lipid | N/A | Made in-house | |
Rubber tipped forceps | Any company | Mix of fine-tipped and flat/square edges recommended | |
Scissors | Any company | ||
Sodium hydroxide - 1 N | Any company | ||
Sodium hydroxide - 10 N | Any company | ||
Spectrofluorometer | Any company | Capable of 410 nm excitation and 600-850 nm emission | |
Spectrofluorometry software | Horiba | FluorEssence | |
Spectrometer | Any company | ||
Syringe - 1 mL | Any company | Disposible, plastic, sterile | |
Syringe filters - 0.2 micron pore size | Any company | Membrane material: PES or other compatible with ammonium acetate/acetic acid and PBS | |
Test tube - 10 mL | |||
Triton X-100 | Any company | ||
Vacuum desicator/vacuum | Any company | ||
Vialmix | Lantheus Medical Imaging | 515030-0508 | Referred to in protocol as a mechanical vial shaker |
Weigh paper | Any company | To avoid losing product, cutting weigh paper into 3x3 cm squares is recommended |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved